Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT-064040 nasal spray in healthy volunteers
NCT07016516Phase 1Completed
- Sponsor
- Sichuan Prite Pharmaceutical
- Start
- Jun 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of PRT-064040 in migraine (4 arms), sponsored by Sichuan Prite Pharmaceutical. Primary endpoint: Adverse Events. Started Jun 2025; status: completed.
02
Drugs
PRT-064040
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07016516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07016516.